The E3 ubiquitin ligase WWP1 sustains the growth of acute myeloid leukaemia

The E3 ubiquitin ligase (E3) WWP1 is an oncogenic factor implicated in the maintenance of different types of epithelial cancers. The role of WW domain-containing E3 ubiquitin protein ligase 1 (WWP1) in haematological neoplasms remains unknown. Acute myeloid leukaemia (AML) is characterized by the expansion of malignant myeloid cells blocked at different stages of differentiation. Here we report that the expression of WWP1 is significantly augmented in a large cohort of primary AML patients and in AML cell lines, compared with haematopoietic cells from healthy donors. We show that WWP1 inactivation severely impairs the growth of primary AML blasts and cell lines in vitro. In vivo, we observed a reduced leukaemogenic potential of WWP1-depleted AML cells upon transplantation into immunocompromised mice. Mechanistically, WWP1 inactivation induces the accumulation of its protein substrate p27Kip1, which ultimately contributes to G0/G1 cell cycle arrest of AML blasts. In addition, WWP1 depletion triggers the autophagy signalling and reduces survival of leukaemic cells. Collectively, our findings provide molecular insights into the anti-cancer potential of WWP1 inhibition, suggesting that this E3 is a promising biomarker and druggable target in AML.

[1]  J. Cerhan,et al.  HEMATOLOGIC MALIGNANCIES , 2007, UICC Current Treatment of Cancer.

[2]  Myriam Alcalay,et al.  The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells , 1993, Cell.

[3]  H. Dombret,et al.  All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia. , 1995, Blood.

[4]  S. Minucci,et al.  Constitutive degradation of PML/RARalpha through the proteasome pathway mediates retinoic acid resistance. , 1999, Blood.

[5]  D. Small,et al.  Targeted inhibition of FLT3 overcomes the block to myeloid differentiation in 32Dcl3 cells caused by expression of FLT3/ITD mutations. , 2002, Blood.

[6]  P. Chène.  Inhibiting the p53–MDM2 interaction: an important target for cancer therapy , 2003, Nature Reviews Cancer.

[7]  M. Jäättelä,et al.  Vitamin D analog EB1089 triggers dramatic lysosomal changes and Beclin 1-mediated autophagic cell death , 2005, Cell Death and Differentiation.

[8]  K. Miyazono,et al.  Degradation of the Tumor Suppressor Smad4 by WW and HECT Domain Ubiquitin Ligases* , 2005, Journal of Biological Chemistry.

[9]  J. Wade Harper,et al.  Drug discovery in the ubiquitin–proteasome system , 2006, Nature Reviews Drug Discovery.

[10]  H. Frierson,et al.  Ubiquitin E3 ligase WWP1 as an oncogenic factor in human prostate cancer , 2007, Oncogene.

[11]  Jie Jin,et al.  Arsenic trioxide induces not only apoptosis but also autophagic cell death in leukemia cell lines via up-regulation of Beclin-1. , 2007, Leukemia research.

[12]  Z. Ronai,et al.  Regulation of p53 localization and transcription by the HECT domain E3 ligase WWP1 , 2007, Oncogene.

[13]  Wei Zhou,et al.  The amplified WWP1 gene is a potential molecular target in breast cancer , 2007, International journal of cancer.

[14]  A. Seth,et al.  The WW domain containing E3 ubiquitin protein ligase 1 upregulates ErbB2 and EGFR through RING finger protein 11 , 2008, Oncogene.

[15]  Aaron Ciechanover,et al.  The HECT family of E3 ubiquitin ligases: multiple players in cancer development. , 2008, Cancer cell.

[16]  Thomas Tüting,et al.  Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cells. , 2009, Cancer cell.

[17]  R A Knight,et al.  Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes , 2009, Cell Death and Differentiation.

[18]  L. Platanias,et al.  Autophagy Is a Critical Mechanism for the Induction of the Antileukemic Effects of Arsenic Trioxide* , 2010, The Journal of Biological Chemistry.

[19]  A. Balmain,et al.  Guidelines for the welfare and use of animals in cancer research , 2010, British Journal of Cancer.

[20]  M. Bjørås,et al.  Autophagy contributes to therapy-induced degradation of the PML/RARA oncoprotein. , 2010, Blood.

[21]  G. Melino,et al.  The E3 ubiquitin ligase WWP1 regulates ΔNp63-dependent transcription through Lys63 linkages. , 2010, Biochemical and biophysical research communications.

[22]  T. Tong,et al.  WW Domain-containing E3 Ubiquitin Protein Ligase 1 (WWP1) Delays Cellular Senescence by Promoting p27Kip1 Degradation in Human Diploid Fibroblasts* , 2011, The Journal of Biological Chemistry.

[23]  Yong-mei Zhu,et al.  Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia. , 2011, Blood.

[24]  D. Tang,et al.  Autophagy regulates myeloid cell differentiation by p62/SQSTM1-mediated degradation of PML-RARα oncoprotein , 2011, Autophagy.

[25]  Zhongmei Zhou,et al.  The WWP1 ubiquitin E3 ligase increases TRAIL resistance in breast cancer , 2012, International journal of cancer.

[26]  G. Nybakken,et al.  Terminal myeloid differentiation in vivo is induced by FLT3 inhibition in FLT3/ITD AML. , 2012, Blood.

[27]  Fulvio Reggiori,et al.  Autophagy regulation through Atg9 traffic , 2012, The Journal of cell biology.

[28]  Robert Clarke,et al.  Guidelines for the use and interpretation of assays for monitoring autophagy , 2012 .

[29]  M. Caligiuri,et al.  Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemia. , 2012, Blood.

[30]  M. Tsai,et al.  WWP1 gene is a potential molecular target of human oral cancer. , 2013, Oral surgery, oral medicine, oral pathology and oral radiology.

[31]  Benjamin J. Raphael,et al.  Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. , 2013, The New England journal of medicine.

[32]  D. Green,et al.  Die another way – non-apoptotic mechanisms of cell death , 2014, Journal of Cell Science.

[33]  Hongtao Liu,et al.  WWP1 as a potential tumor oncogene regulates PTEN-Akt signaling pathway in human gastric carcinoma , 2015, Tumor Biology.

[34]  M. Tschan,et al.  WIPI-dependent autophagy during neutrophil differentiation of NB4 acute promyelocytic leukemia cells , 2014, Cell Death and Disease.

[35]  T. Tong,et al.  Knockdown of WWP1 inhibits growth and induces apoptosis in hepatoma carcinoma cells through the activation of caspase3 and p53. , 2014, Biochemical and biophysical research communications.

[36]  H. Pelham,et al.  Peptide and small molecule inhibitors of HECT-type ubiquitin ligases , 2014, Proceedings of the National Academy of Sciences.

[37]  M. Tschan,et al.  Induction of autophagy is a key component of all-trans-retinoic acid-induced differentiation in leukemia cells and a potential target for pharmacologic modulation. , 2015, Experimental hematology.

[38]  Sangeeta Khare,et al.  Guidelines for the use and interpretation of assays formonitoring autophagy (3rd edition) , 2016 .

[39]  J. Tamburini,et al.  Proteasome inhibitors induce FLT3-ITD degradation through autophagy in AML cells. , 2016, Blood.

[40]  P. Chène.  INHIBITING THE p 53 – MDM 2 INTERACTION : AN IMPORTANT TARGET FOR CANCER THERAPY , 2022 .